MYCN and prostate carcinoma: Changes in the N-Myc cistrome, its interacting co-factors, and N-Myc-directed epigenomic reprogramming are androgen-dependent and drive a lineage switch in prostate cancer epithelial cells towards a neural identity that favors the development of AR independence and NEPC5–7.